Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
149 participants
INTERVENTIONAL
2007-10-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This trial will test the hypothesis that if the clinician post-dates the delayed prescription by 2 days, rather than dating it on the day the patient is seen, there will be a further drop in the rate of antibiotic use.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study.
NCT02282384
Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults
NCT00793000
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
NCT01224795
Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age
NCT00593502
Effect of Early Antiviral Therapy on Duration of Cough in Flu Patients
NCT03618407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is hypothesised that post-dating the prescription will result in a reduced cashing rate.
Each arm of the study (Usual v Post-Dated) will contain 75 subjects. This sample will have the power to detect a 25% change in prescription use.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Post-Dated Prescription
a delayed prescription dated 2 days after clinical office visit
A delayed prescription dated 2 days after clinical office visit
Usual
usual date
Usual Dated
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A delayed prescription dated 2 days after clinical office visit
Usual Dated
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults with an untreated upper respiratory tract infection
* Adults presenting for the first time to a family physician or a nurse practitioner
Exclusion Criteria
* Having a clear indication for antibiotic therapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial University of Newfoundland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial University
St. John's, Newfoundland and Labrador, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
worrall1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.